Showing results (6041-6050 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 23, 2012
Targeted ultrasound imaging of cancer: an emerging technology on its way to clinicsFabian Kiessling, Jessica Bzyl, Stanley Fokong, et al.Current Pharmaceutical Design|January 31, 2012
Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitusRobert Stohr, Nikolaus MarxCurrent Pharmaceutical Design|January 13, 2012
"Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitryKenneth Blum, Eliot Gardner, Marlene Oscar-Berman, et al.Current Pharmaceutical Design|January 13, 2012
Ghrelin and the brain-gut axis as a pharmacological target for appetite controlInge Seim, Magdy El-Salhy, Trygve Hausken, et al.Current Pharmaceutical Design|January 14, 2012
The vulnerability to schizophrenia mainstream research paradigms and phenomenological directionsGiovanni Stanghellini, Paolo Fusar-PoliCurrent Pharmaceutical Design|January 14, 2012
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorderA Bechdolf, A Ratheesh, S J Wood, et al.Current Pharmaceutical Design|January 14, 2012
Relationship between gyrification and functional connectivity of the prefrontal cortex in subjects at high genetic risk of schizophreniaMaria R Dauvermann, Prerona Mukherjee, William T Moorhead, et al.Current Pharmaceutical Design|January 14, 2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairmentsO D Howes, P Fusar-Poli, M Bloomfield, et al.Current Pharmaceutical Design|January 14, 2012
Cingulate volume abnormalities in emerging psychosisMichel Röthlisberger, Anita Riecher-Rössler, Jacqueline Aston, et al.Pageof 1,008